Alan E. Dow

Corporate Officer/Principal at COMPLETE GENOMICS, INC.

69 year

Consumer Services

Health Technology

Profile

Alan E.
Dow is currently the VP-Intellectual Property & legal Affairs at Complete Genomics, Inc. Previously, he worked as the Vice President & General Counsel at Vical, Inc. from 2001 to 2004, and as an Attorney at Acuity Law Group from 2004 to 2008.
Dr. Dow holds a doctorate degree from Harvard University, a graduate degree from Stanford University, and an undergraduate degree from the University of Maine.

Alan E. Dow active positions

Companies	Position	Start
COMPLETE GENOMICS, INC.	Corporate Officer/Principal	31/08/2008

All active positions of Alan E. Dow

Former positions of Alan E. Dow

Companies	Position	End
Acuity Law Group	Corporate Officer/Principal	31/08/2008
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	General Counsel	30/06/2004

See the detail of Alan E. Dow's experience

Training of Alan E. Dow

Harvard University	Doctorate Degree
Stanford University	Graduate Degree
University of Maine	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alan E. Dow's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	Health Technology
Complete Genomics, Inc. Complete Genomics, Inc. BiotechnologyHealth Technology Complete Genomics, Inc. develops and markets DNA sequencing technology. It provides complete genomics analysis platform, which combines its proprietary human genome sequencing technology with the company's advanced informatics and data management software. The firm offers innovative, end-to-end, outsourced service model to the customers with data. The company was founded by Clifford A. Reid, Radoje T. Drmanac, David Smith and Robert John Curson in 2006 and is headquartered in San Jose, CA.	Health Technology
Acuity Law Group

See company connections